KRISTINA MCCUTCHEN: Open Payments
NPI 1588843544 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 41 payments from 15 companies in 2025. Trend: 2023 $988 · 2024 $680 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $275 |
| Forte Bio-Pharma LLC | 5 | $73 |
| SI-BONE, INC. | 3 | $64 |
| PROTEGA PHARMACEUTIALS INC | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| TerSera Therapeutics LLC | 1 | $35 |
| MML US, Inc. | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $23 |
Products named: BOTOX, QULIPTA, PROLATE, ROXYBOND, RELISTOR, UBRELVY, Prialt, Belbuca.
Industry payments across NE — which companies pay providers there.
